TLR9 and metabolic dysfunction-associated steatotic liver disease: Tlr9−/− mice fed with a choline‐deficient L‐amino‐defined diet for induction of NAFLD show reduced steatohepatitis and liver fibrosis compared to WT mice, indicating that TLR9 is a driver for fatty liver disease.